Xttrium Laboratories, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1200 E. Business Center Drive, Mount Prospect, Illinois (IL) 60056, United States (USA)
- Operations here
- api manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3008436464 · DUNS 007470579
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 9 drugs, 1 already in shortage. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2025-06-18
- VAIDrug Quality Assurance2024-03-08
- NAIBioresearch Monitoring2024-02-06
- VAIDrug Quality Assurance2018-03-15
- VAIDrug Quality Assurance2016-07-11
- VAIBioresearch Monitoring2016-05-25
- VAIDrug Quality Assurance2013-12-05
- NAIBioresearch Monitoring2013-01-15
- NAIDrug Quality Assurance2012-12-11
- NAIDrug Quality Assurance2011-10-20
- VAIDrug Quality Assurance2011-07-18
- VAIPostmarket Surv. and Epidemiology2011-07-18
- NAIDrug Quality Assurance2010-07-16
- VAIDrug Quality Assurance2010-02-19
- NAIDrug Quality Assurance2009-08-20
- OAIDrug Quality Assurance2008-12-31
Drugs this plant is listed as making
9 distinct drugs across 17 products name this site in their FDA label.
- 0.12% Chlorhexidine GluconateMajor Pharmaceuticals
- AmantadineXttrium Laboratories, Inc
- Chlorhexidine GluconateMcKesson
- Chlorhexidine Gluconate 0.12% Oral RinseXttrium Laboratories, Inc.
- LactuloseXttrium Laboratories, Inc.
- Lidocaine hydrochloridein shortageXttrium Laboratories, Inc.
- NystatinXttrium Laboratories, Inc.
- Valproic AcidXttrium Laboratories Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.